Publikationen in Zusammenarbeit mit Forschern von Instituto de Química Médica (11)

2024

  1. Periodic table screening for enhanced positive contrast in MRI and in vivo uptake in glioblastoma

    Chemical Science, Vol. 15, Núm. 22, pp. 8578-8590

  2. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

    Nanoscale, Vol. 16, Núm. 13, pp. 6477-6487

2023

  1. A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque

    ACS Nano, Vol. 17, Núm. 14, pp. 13811-13825

  2. Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review

    ACS Applied Nano Materials, Vol. 6, Núm. 22, pp. 20523-20538

2021

  1. Delayed alveolar clearance of nanoparticles through control of coating composition and interaction with lung surfactant protein A

    Materials Science and Engineering C

  2. Digitonin concentration is determinant for mitochondrial supercomplexes analysis by BlueNative page

    Biochimica et Biophysica Acta - Bioenergetics, Vol. 1862, Núm. 1

  3. HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 38, pp. 45279-45290

2020

  1. Iron oxide nanoparticles: An alternative for positive contrast in magnetic resonance imaging

    Inorganics, Vol. 8, Núm. 4

  2. Thrombo-tag, an: In vivo formed nanotracer for the detection of thrombi in mice by fast pre-targeted molecular imaging

    Nanoscale, Vol. 12, Núm. 45, pp. 22978-22987

2019

  1. Cu-Doped Extremely Small Iron Oxide Nanoparticles with Large Longitudinal Relaxivity: One-Pot Synthesis and in Vivo Targeted Molecular Imaging

    ACS Omega, Vol. 4, Núm. 2, pp. 2719-2727

  2. Unambiguous detection of atherosclerosis using bioorthogonal nanomaterials

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 26-35